Redefining Therapeutic Paradigms for Microtubule Inhibitors

Physicians Education Resource
05.06.2010  Chicago
Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the ASCO Cancer Foundation.
Contenuti (corsi)
Satellite symposium will highlight advances in the use of novel cytotoxic agents for the treatment of metastatic breast cancer (MBC), non–small-cell lung cancer (NSCLC), pancreatic cancer, and melanoma. Recent data indicate that novel taxane formulations and other microtubule-interacting agents might improve the therapeutic index in MBC and NSCLC. In addition, these agents are demonstrating activity in melanoma and pancreatic cancer, malignancies that have been resistant to traditional...
Obiettivi didattici, obiettivi del training
Please see our websie for all the details
Pubblico target
medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer, NSCLC, pancreatic cancer, and melanoma. Fellows, nurse practitioners, nurses, physician assistants, practitioners, nurses, physician assistants

Informazioni ed Iscrizioni:

Mr. Duane Fowler
no registration fee
Contatto organizzatori
3500 Maple Ave. Ste. 700
75219 Dallas
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation European Public Health Association (EUPHA)newTreeAlumni Club Medizinische Universität WienSwiss Tropical and Public Health InstituteAMREF - African Medical and Research FoundationCenter of ExcellenceHilfswerk Austria